You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 113 No. 8, August 1995 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorials
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (5)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Interferon: Friend or Foe?

Rosa Ana Tang, MD, MPH

Arch Ophthalmol. 1995;113(8):987.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

INTERFERONS ARE a group of naturally occurring proteins with large molecular weight that have multiple complex activity against viruses, tumors, and even angiogenesis. Of the several types of interferons, interferon alfa has been used most widely for treatment of hairy cell leukemia and other cancers.1 Common systemic side effects are a flulike syndrome as well as hypotension and tachycardia.2 At high doses, the interferons are neurotoxic, causing electroencephalographic abnormalities similar to those associated with diffuse encephalitis as well as cognitive and behavioral changes.3

Ocular side effects, such as oculomotor paralysis (one case), eyelash hypertrichosis (two cases), and a mostly reversible type of vaso-occlusive retinopathy, have been described.4 The retinopathy is characterized by the presence of cotton wool spots, areas of retinal capillary non-perfusion, vascular occlusions, leakage, hemorrhages, and edema of the retina.

See also page 1041

The incidence of retinopathy has been recently studied in 63 . . . [Full Text PDF of this Article]


Author Affiliations

Galveston and Houston, Tex



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.